Stratifind is an oncology diagnostics company advancing RNA + DNA–based prognostic and predictive testing to improve cancer treatment decisions. Our platform goes beyond mutation detection to identify which patients are most likely to respond to specific therapies, empowering oncologists with actionable insights and enabling biopharma partners to accelerate translational research and drug development. We also work with diagnostics innovators who are uncertain about commercialization, reimbursement, or clinical adoption—helping them navigate complexity and find the right path forward. Anchored in tissue-based gene expression and enhanced with algorithmic interpretation, Stratifind is engaging a CLIA-certified lab, pursuing reimbursement pathways, and forging partnerships to scale precision oncology. Our mission is simple: bring clarity to cancer care, advance translational research, and guide emerging diagnostics companies toward meaningful impact.
| Website | https://stratifind.io |
| Employees | 4 (0 on RocketReach) |
| Founded | 2025 |
| Industry | Medical and Diagnostic Laboratories |
Looking for a particular Stratifind employee's phone or email?
Stratifind is based in New York, New York.